Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.46 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.37 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.36 |
| ▸ | CAD | P27708 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL123379 | 1.00 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28868945 | 1.00 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28868944 | 1.00 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1338854 | 1.00 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1338852 | 1.00 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 | |
| SCHEMBL111398 | 0.98 | — | — | |
| SCHEMBL111397 | 0.98 | — | — | |
| SCHEMBL6744341 | 0.98 | — | — | |
| SCHEMBL22830533 | 0.95 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 | |
| SCHEMBL22830532 | 0.95 | PTGS1 (0.46) | PTGS1SLC7A11CPB2ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | FIRMENICH SA (CH) | 2025-10-07 | — | — | US | claimed |
| US-20230210735-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | FIRMENICH SA (CH) | 2023-07-06 | — | — | US | claimed |
| US-20230159476-A1 | PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME | ELIKIMIA INC (CA) | 2023-05-25 | — | — | US | claimed |
| EP-4164587-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | Firmenich SA (CH) | 2023-04-19 | — | — | EP | claimed |
| CN-115768755-A | Method for synthesizing compounds absorbing ultraviolet radiation under flow conditions and formulations containing the same | 爱尔克米亚公司 | 2023-03-07 | — | — | CN | claimed |
| US-20210395638-A1 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS AND FOOD RAW MATERIALS | FIRMENICH SA (CH) | 2021-12-23 | — | — | US | claimed |
| WO-2021250130-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | FIRMENICH SA (CH) | 2021-12-16 | — | — | WO | claimed |
| EP-3856358-A2 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS AND FOOD RAW MATERIALS | Firmenich SA (CH) | 2021-08-04 | — | — | EP | claimed |
| CN-113038928-A | Preventing oxidation of flavor and food materials | 弗门尼舍有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-111100840-A | Magnetic nano-composite for specifically capturing and effectively releasing circulating tumor cells and preparation method thereof | 湖北工业大学 | 2020-05-05 | — | — | CN | claimed |
| US-20110206606-A1 | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION | BRACCO IMAGING S.P.A. (IT) | 2011-08-25 | — | — | US | claimed |
| US-20070269375-A1 | Stable Radiopharmaceutical Compositions and Methods for Preparation | BRACCO IMAGING S.P.A. (IT) | 2007-11-22 | — | — | US | claimed |
| EP-1654005-A2 | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION | BRACCO IMAGING S.p.A. (IT) | 2006-05-10 | — | — | EP | claimed |
| WO-2005009393-A2 | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION | BRACCO IMAGING S.P.A. (IT) | 2005-02-03 | — | — | WO | claimed |
| EP-0580860-B2 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 2004-12-15 | — | — | EP | claimed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| EP-4731739-A1 | NEW COMPOUNDS | Givaudan SA (CH) | 2026-04-29 | — | — | EP | disclosed |
| US-4130713-A | Biotin intermediates | HOFFMANN-LA ROCHE INC. (US) | 1978-12-19 | — | — | US | disclosed |
| US-4069322-A | Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids | INTERX RESEARCH CORPORATION (US) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110206606-A1 | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION | GRPR, GIPR, SSTR3 | PTGS1 4001/4885GAA 1030/4885SLC7A11 3831/4885 |
| US-20230159476-A1 | PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME | ERCC4, XPA, ERCC1 | PTGS1 891/4885GAA 307/4885SLC7A11 2677/4885 |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | CUTA, MPO, GPX4 | PTGS1 539/4885GAA 1819/4885SLC7A11 3781/4885 |
| US-20230210735-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | ACHE, RBP4, LPO | PTGS1 925/4885GAA 1373/4885SLC7A11 2861/4885 |
| US-20070269375-A1 | Stable Radiopharmaceutical Compositions and Methods for Preparation | GRPR, GIPR, SSTR3 | PTGS1 4001/4885GAA 1030/4885SLC7A11 3831/4885 |
| US-20210395638-A1 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS AND FOOD RAW MATERIALS | CUTA, MPO, GPX4 | PTGS1 539/4885GAA 1819/4885SLC7A11 3781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.